Rivaroxaban is the only NAO, with a study that considered interruption of treatment, for apixaban and dabigatran further studies are needed. There are no reports of interaction between rivaroxaban ...

Rivaroxaban and apixaban, both NOACs, exert their anticoagulant effects via a different mechanism than that of dabigatran. These drugs work by directly inhibiting factor Xa in the coagulation cascade.

However, dabigatran etexilate is also expected to face competition soon from other OACs in development, in particular rivaroxaban (Xarelto; Bayer/Johnson & Johnson). Rivaroxaban, which is most ...

Further trials comparing aspirin with newer anticoagulants (dabigatran, apixaban and rivaroxaban) are necessary to assess the role of each agent in stroke prevention in patients with AF.

Acute left ventricular thrombus occurs in about 3% of all patients with STEMI. Rivaroxaban demonstrated similar efficacy and safety to warfarin for resolution of left ventricular thrombus after ...

TUESDAY, Feb. 11, 2025 (HealthDay News) -- Rates of major bleeding and intracranial hemorrhage are similar for apixaban and dabigatran versus aspirin, while rates are higher for rivaroxaban ...

A score of 1 in individualized in regards to using aspirin versus full anticoagulation with warfarin, dabigatran or rivaroxaban. When the CHADS 2 score is > 2, full anticoagulation is recommended ...

Boehringer only publishes yearly results, but in all of last year Pradaxa generated sales of 1.486 billion euros ($1.6 billion). FDA approval for Xarelto in the new indication is based on data ...